DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
01 3Dr. Reddy's Laboratories
02 1Olpha
03 3NanoAlvand
04 2Aizant Drug Research Solutions Pvt. Ltd.
05 2Aurobindo Pharma Limited
06 3Bluepharma
07 2Chia Tai Tianqing Pharmaceutical Group
08 2Cipla
09 3Cipla Medpro South Africa
10 3Dr Reddy's Laboratories (Pty) Ltd
11 1Genex Pharma
12 3MSN Laboratories
13 1NANO DARU
14 2Natco Pharma
15 3Pfizer Consumer Healthcare
16 48Pfizer Inc
17 3Pharmascience Inc.
18 6Pinnacle Life Science
19 3Pluviaendo
20 3Sun Pharmaceutical Industries Limited
21 3Taro Pharmaceutical Industries
22 3Tecnimede
23 1TherDose Pharma
24 3XYZ Pharma
25 3Zydus Lifesciences
01 9CAP
02 6CAPSULE
03 3CAPSULE; ORAL
04 13CAPSULE;ORAL
05 17Capsule
06 3Capsules
07 15Film Coated Tablet
08 3Film-Coated Tablet
09 6Hard Capsule
10 6Hard Capsules
11 3Hard Gelatin Capsule
12 3Oral
13 9TABLET
14 6TABLET;ORAL
15 4Tablet
16 1Tablets
17 3Blank
01 6Allowed
02 6Approved
03 6Authorized
04 3DISCN
05 1Dossier Readiness: Q3 2025
06 6Generic
07 3Marketed
08 3Not Marketed
09 3Originator
10 9PRESCRIPTION
11 12Prescription
12 6RX
13 46Blank
01 3Cybrin
02 9IBRANCE
03 1ISOGEN
04 39Ibrance
05 20PALBOCICLIB
06 2PALBOCICLIB CAPSULES
07 1PALVORED 100
08 1PALVORED 125
09 1PALVORED 75
10 3PMS-PALBOCICLIB
11 9Palbociclib
12 1Palbociclib 100 mg Cipla
13 1Palbociclib 125 mg Cipla
14 1Palbociclib 75 mg Cipla
15 1Palbociclib Pfizer 100 mg
16 1Palbociclib Pfizer 125 mg
17 1Palbociclib Pfizer 75 mg
18 3TARO-PALBOCICLIB
19 12Blank
01 3Australia
02 9Canada
03 6Denmark
04 6Estonia
05 11India
06 4Iran
07 1Latvia
08 6Norway
09 6Portugal
10 9South Africa
11 6Spain
12 6Sweden
13 6Switzerland
14 3Turkey
15 28USA
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Palbociclib
Dosage Form : Oral
Dosage Strength : 75 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
Olpha, a JSC AB City subsidiary, is a leading Baltic firm with 50 years of experience in medicines & chemical pharmaceuticals.
Regulatory Info : Dossier Readiness: Q3 2025
Registration Country : Latvia
Brand Name :
Dosage Form : Tablet
Dosage Strength :
Packaging :
Approval Date :
Application Number :
Regulatory Info : Dossier Readiness: Q3 2025
Registration Country : Latvia
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Palbociclib
Dosage Form : Oral
Dosage Strength : 100 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name : Palbociclib
Dosage Form : Oral
Dosage Strength : 125 mg
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.
Regulatory Info :
Registration Country : Iran
Brand Name : Cybrin
Dosage Form : Hard Gelatin Capsule
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Iran
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213086
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 213086
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 212980
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 212980
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE
Dosage Strength : 125MG
Packaging :
Approval Date :
Application Number : 213089
Regulatory Info :
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE
Dosage Strength : 100MG
Packaging :
Approval Date :
Application Number : 213089
Regulatory Info :
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : CAPSULE;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2015-02-03
Application Number : 207103
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 100MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : IBRANCE
Dosage Form : TABLET;ORAL
Dosage Strength : 125MG
Packaging :
Approval Date : 2019-11-01
Application Number : 212436
Regulatory Info : RX
Registration Country : USA
Regulatory Info :
Registration Country : USA
Brand Name : PALBOCICLIB
Dosage Form : CAPSULE;ORAL
Dosage Strength : 75MG
Packaging :
Approval Date :
Application Number : 213091
Regulatory Info :
Registration Country : USA
